Related Experiment Video
Updated: Feb 11, 2026

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
Published on: November 2, 2013
Are We Eating Our Way to Prostate Cancer-A Hypothesis Based on the Evolution, Bioaccumulation, and Interspecific
Venkatesh Vaidyanathan1, Vetrivhel Krishnamoorthy2, Nishi Karunasinghe3
1Discipline of Nutrition and Dietetics, FM & HS, University of Auckland, Auckland 1023, New Zealand. v.vaidyanathan@auckland.ac.nz.
Abstract:
MicroRNAs (miRNAs) are well established epigenetic modifiers. There is a lot of work being done to identify the evolutionary transfer of miRNAs both at intra- and interspecific levels. In this hypothesis-driven review, we have suggested a possible reason as to why miR-150 can be a promising diagnostic biomarker for prostate cancer using theories of evolution, bio-accumulation, and interspecific transfer of miRNAs.
Insights
MicroRNAs (miRNAs) are epigenetic modifiers. This review hypothesizes that miR-150 may serve as a promising diagnostic biomarker for prostate cancer due to evolutionary transfer and bio-accumulation.
Area of Science:
- Epigenetics
- Evolutionary Biology
- Biomarker Discovery
Background:
- MicroRNAs (miRNAs) are key epigenetic regulators.
- Research is actively exploring the evolutionary transfer of miRNAs between species.
- Understanding miRNA evolution is crucial for biomarker development.
Purpose of the Study:
- To propose a hypothesis for miR-150's potential as a prostate cancer diagnostic biomarker.
- To explore the roles of evolutionary theories, bio-accumulation, and interspecific miRNA transfer in this context.
Main Methods:
- Hypothesis-driven review.
- Integration of evolutionary biology principles.
- Analysis of miRNA bio-accumulation and interspecific transfer mechanisms.
Main Results:
- miR-150 is identified as a potential candidate biomarker.
- Evolutionary transfer and bio-accumulation are proposed as mechanisms influencing miR-150 levels.
- The study provides a theoretical framework for miR-150's diagnostic utility.
Conclusions:
- miR-150 shows promise as a non-invasive biomarker for prostate cancer.
- Further research into miRNA evolutionary dynamics can uncover novel diagnostic tools.
- This hypothesis lays the groundwork for experimental validation.
Related Concept Videos
The Evidence for Evolution
Convergent Evolution
Binge Eating Disorders
What is a Hypothesis?
Types of Hypothesis Testing
When the null and alternative hypotheses are stated, it is observed that the null hypothesis is a neutral statement against which the alternative hypothesis is tested. The alternative hypothesis is a claim that instead has a certain direction. If the null hypothesis claims that p = 0.5, the alternative hypothesis would be an opposing statement to this and can be put either p > 0.5, p < 0.5, or p...
Errors In Hypothesis Tests

